Leading German Medical Cannabis Wholesaler - Import, Export, Distribution, Online Presence, Strategic Partnership Opportunity

Leading German Medical Cannabis Wholesaler - Import, Export, Distribution, Online Presence, Strategic Partnership Opportunity
Buy / Sell / Invest:
Partner or Joint Venture
Location:
Germany

German medical cannabis distributor with sales network into German pharmacies & global markets seeks a strategic partner to invest €3-5 million for a substantial ownership position, & to fuel expansion plans. Projecting €5 million revenue in 2024!

  • Licensed German medical cannabis wholesaler importing, exporting & distributing a range of medicinal cannabis product forms selling in Germany, as well as other global markets
  • Currently conducting import and distribution of dried flower, extracts, finished medical cannabis products and API in bulk and jars. Also providing in-house branding and white labelling services, B2B and B2C sales
  • Operating from licensed, leased premises in a commercial building, incorporating offices and lab space to support imports, as well as an EU-GMP partner processing and storage facility
  • Experienced, industry-leading team with deep expertise navigating German, European and global medical cannabis markets, with a firm grasp on the recreational cannabis market opportunity in Germany and the rest of Europe
  • Company has differentiated digital infrastructure and online assets providing significant competitive advantage
  • Working with an increasing number of suppliers as a “launch pad” into the German market, via white-label packaging, distribution and market access services
  • Business is lean and efficient, operating at a low monthly burn rate with low debts
  • Identified as one of the Top 20 Cannabis Distributors in Germany
  • The Company is highly involved and up-to-date with the legal proposals for cannabis legalization in Germany
  • Company is at break-even in 2022 and 2023 and is forecasting imminent cash flow positive status with ~€5 million projected annual sales in 2024
  • Company is well-equipped with contracts for the European cannabis industry surge set to commence in 2024
  • Company can also perform research on psychedelics under the existing licences
  • Looking for a strategic partner or a merger to build on its unique platform, further scaling commercial operations and expanding to meet clientele demands in Europe

Licence(s) Held:

  • Narcotics Licence, GDP Distribution Licence

 

Seeking strategic equity partner to fund continued growth

 
View Listing

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.